{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:28:43Z","timestamp":1772432923738,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA225730"],"award-info":[{"award-number":["U01 CA225730"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbc.2025.110431","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:58:56Z","timestamp":1751421536000},"page":"110431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Restricted human CD45 isoglycoforms serve as functional E-selectin ligands and delineate hematopoietic maturity"],"prefix":"10.1016","volume":"301","author":[{"given":"Evan","family":"Ales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sackstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110431_bib1","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/j.1460-2075.1994.tb06716.x","article-title":"The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation","volume":"13","author":"Desai","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.110431_bib2","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.88.6.2037","article-title":"Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production","volume":"88","author":"Koretzky","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110431_bib3","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1084\/jem.166.5.1548","article-title":"Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens","volume":"166","author":"Streuli","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbc.2025.110431_bib4","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.4049\/jimmunol.164.10.5287","article-title":"Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors","volume":"164","author":"Gerdy","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.110431_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jbc.2025.110431_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ni877","article-title":"CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling","volume":"4","author":"Irles","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2025.110431_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-2478(99)00012-7","article-title":"Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45","volume":"67","author":"Walzel","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jbc.2025.110431_bib8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1074\/jbc.M109.066191","article-title":"N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death","volume":"285","author":"Earl","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110431_bib9","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.febslet.2013.10.034","article-title":"Regulation of galectin-3-induced apoptosis of Jurkat cells by both O-glycans and N-glycans on CD45","volume":"587","author":"Xue","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2025.110431_bib10","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1038\/s41467-018-05770-9","article-title":"Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans","volume":"9","author":"Giovannone","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110431_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0092-8674(91)90036-X","article-title":"The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells","volume":"66","author":"Stamenkovic","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110431_bib12","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.1103433","article-title":"Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression","volume":"188","author":"Cedeno-Laurent","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.110431_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13941","article-title":"CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia","volume":"173","author":"Kersten","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jbc.2025.110431_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","article-title":"Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia","volume":"19","author":"Goardon","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110431_bib15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/s41467-020-15817-5","article-title":"Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance","volume":"11","author":"Barbier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110431_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1083\/jcb.153.6.1277","article-title":"CD44 is a major E-selectin ligand on human hematopoietic progenitor cells","volume":"153","author":"Dimitroff","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110431_bib17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/nm.2969","article-title":"Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2025.110431_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/bs.acr.2022.07.001","article-title":"The biology of E-selectin ligands in leukemogenesis","volume":"157","author":"Ales","year":"2023","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110431_bib19","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood-2010-11-320705","article-title":"Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem\/progenitor cells","volume":"118","author":"Merzaban","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110431_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/cancers11091253","article-title":"Acute myeloid and lymphoblastic leukemia cell interactions with endothelial selectins: critical role of PSGL-1, CD44 and CD43","volume":"11","author":"Spertini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2025.110431_bib21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1900679","article-title":"sLeX expression delineates distinct functional subsets of human blood central and effector memory T cells","volume":"205","author":"Silva","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.110431_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1189\/jlb.0710404","article-title":"Pivotal advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation","volume":"90","author":"Koethe","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jbc.2025.110431_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.2021010721","article-title":"Phase 1\/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia","volume":"139","author":"DeAngelo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110431_bib24","doi-asserted-by":"crossref","first-page":"eadi1145","DOI":"10.1126\/scitranslmed.adi1145","article-title":"Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy","volume":"15","author":"Wellhausen","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2025.110431_bib25","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1084\/jem.20080072","article-title":"CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules","volume":"205","author":"Shivtiel","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbc.2025.110431_bib26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.exphem.2011.08.012","article-title":"CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice","volume":"39","author":"Shivtiel","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jbc.2025.110431_bib27","doi-asserted-by":"crossref","first-page":"64785","DOI":"10.18632\/oncotarget.11622","article-title":"CD45 phosphatase is crucial for human and murine acute myeloid leukemia maintenance through its localization in lipid rafts","volume":"7","author":"Saint-Paul","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.110431_bib28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41375-023-01897-x","article-title":"FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4\/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML","volume":"37","author":"Jia","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2025.110431_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41409-020-01000-3","article-title":"Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma","volume":"56","author":"Tuazon","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jbc.2025.110431_bib30","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.4049\/jimmunol.1601636","article-title":"Cell-specific variation in E-selectin ligand expression among human peripheral blood mononuclear cells: implications for immunosurveillance and pathobiology","volume":"198","author":"Silva","year":"2017","journal-title":"J. Immunol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825022811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825022811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T23:30:45Z","timestamp":1756423845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825022811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0021925825022811"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110431","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restricted human CD45 isoglycoforms serve as functional E-selectin ligands and delineate hematopoietic maturity","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110431"}}